Close
Contact Us. You can also follow us on Twitter "MexicoFarmacia" Send us your comments, we appreciate all comments.
Close
On this page, we write (Blog) about recent topics relative to our line of Business, HealthCare.

wholesale distributor of pharmaceuticals & medical devices



Recent Blogs

Pro-Medical Awared RTI Distribution in Mexico... Posted by: Maria Refugio | Marketing StrategistDec 10, 2009
Retractable Technologies Inc. of Texas; the manufacturer of VanishPoint® safety products. Which virtually eliminate the risk of contaminated needlestick injuries that can transmit HIV, hepatitis (B and C), and many other infectious bloodborne diseases. Today awarded National Distribution right(s) within Mexico to Dr Giorgio Patino of Surtidora Pro-Medical SA de CV. This mutually beneficial relationship sets out to set the standard of excellence, effectiveness and integrity in selling and delivery of VanishPoint Syringes and Catheters.
Read More

Cipla Ltd. Grants Surtidora Pro-Medical Distrib... Posted by: Natalia Lemus | Mkt. Strategist Sept 08, 2009
Distribution rights for Mexico. Today finalized months of negotiations between Surtidora Pro-Medical SA de CV of Puerto Vallarta, Mexico and Nilesh Pawar and Cipla Ltd Pharma Divison of Mumbai, India. Under this agreement Surtidora will now begin to import and pre-register generic versions of pharmaceutical molecules from Cipla's pharma division in Mumbai, Bangalore, Goa and Vikhroli. Registration must be approved by the Dept De Salud and the SSA of Mexico pertaining to all potential imported products; that still must be registerd in the Cuadro Basico or Medical Guideline registrar of Mexico.
Read More

2009 H1N1 Flu (Swine Flu) and You... Posted by: Mari | Marketing Strategist Oct 16, 2009
2009 H1N1 (sometimes called “swine flu”) is a new influenza virus causing illness in people. This new virus was first detected in people in the United States in April 2009. This virus is spreading from person-to-person worldwide, probably in much the same way that regular seasonal influenza viruses spread. On June 11, 2009, the World Health Organization (WHO) signaled that a pandemic of 2009 H1N1 flu was underway.
Read More

2009 H1N1 Flu Vaccine Posted by: Natalia Garcia | Marketing t Oct 15, 2009
Supplies of 2009 H1N1 vaccine are limited but continue to increase. More doses are expected for shipment each week. Due to early availability and high demand of seasonal flu vaccine, limited amounts of seasonal supply remain. At this point, CDC continues to encourage those at highest risk from flu complications to seek seasonal flu vaccine and receive 2009 H1N1 vaccine, as recommended.
Read More

Competencia y Precios en Mercado Rx de Mexico Posted by: Mari Refugio | Marketing Oct 07, 2009
Las formas que asume la competencia en el mercado definen el nivel de precios. El mercado farmacéutico contiene submercados con diferente grado de competencia; por un lado existen productos innovadores con patente y, por el otro, genéricos con marca comercial o sin ella. Por lo general, los medicamentos innovadores con patente tienen precios monopólicos, pero a su vencimiento éstos bajan al enfrentar la competencia de alternativas terapéuticas. La marca permite conservar las rentas económicas del monopolio. En México los precios de los medicamentos en el mercado privado son elevados, de acuerdo con las estimaciones agregadas y para medicamentos específicos, lo cual refleja las limitaciones de la competencia en el mercado y el poder de la marca comercial. En el segmento público se obtienen precios competitivos con la estrategia de los medicamentos esenciales de la Organización Mundial de la Salud, con base en el listado de productos del Cuadro Básico.
Read More